Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, M.
Right arrow Articles by Schuh, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, M.
Right arrow Articles by Schuh, A. C.
Related Collections
Right arrow Immunobiology
Right arrow Transfusion Medicine
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 March 2002, Vol. 99, No. 5, pp. 1683-1691

IMMUNOBIOLOGY

Cell surface antigen CD109 is a novel member of the alpha 2 macroglobulin/C3, C4, C5 family of thioester-containing proteins

Martin Lin, D. Robert Sutherland, Wendy Horsfall, Nicholas Totty, Erik Yeo, Rakash Nayar, Xiang-Fu Wu, and Andre C. Schuh

From the Departments of Medical Biophysics, and Medicine, and the Institute of Medical Science, University of Toronto; the Division of Hematology/ Medical Oncology, The Princess Margaret Hospital, Toronto, ON, Canada; and the Imperial Cancer Research Fund, London, United Kingdom.

Cell surface antigen CD109 is a glycosylphosphatidylinositol (GPI)-linked glycoprotein of approximately 170 kd found on a subset of hematopoietic stem and progenitor cells and on activated platelets and T cells. Although it has been suggested that T-cell CD109 may play a role in antibody-inducing T-helper function and it is known that platelet CD109 carries the Gov alloantigen system, the role of CD109 in hematopoietic cells remains largely unknown. As a first step toward elucidating the function of CD109, we have isolated and characterized a human CD109 cDNA from KG1a and endothelial cells. The isolated cDNA comprises a 4335 bp open-reading frame encoding a 1445 amino acid (aa) protein of approximately 162 kd that contains a 21 aa N-terminal leader peptide, 17 potential N-linked glycosylation sites, and a C-terminal GPI anchor cleavage-addition site. We report that CD109 is a novel member of the alpha 2 macroglobulin (alpha 2M)/C3, C4, C5 family of thioester-containing proteins, and we demonstrate that native CD109 does indeed contain an intact thioester. Analysis of the CD109 aa sequence suggests that CD109 is likely activated by proteolytic cleavage and thereby becomes capable of thioester-mediated covalent binding to adjacent molecules or cells. In addition, the predicted chemical reactivity of the activated CD109 thioester is complementlike rather than resembling that of alpha 2M proteins. Thus, not only is CD109 potentially capable of covalent binding to carbohydrate and protein targets, but the t1/2 of its activated thioester is likely extremely short, indicating that CD109 action is highly restricted spatially to the site of its activation.

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Doan and P. G. W. Gettins
{alpha}-Macroglobulins Are Present in Some Gram-negative Bacteria: CHARACTERIZATION OF THE {alpha}2-MACROGLOBULIN FROM ESCHERICHIA COLI
J. Biol. Chem., October 17, 2008; 283(42): 28747 - 28756.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. W. Finnson, B. Y. Y. Tam, K. Liu, A. Marcoux, P. Lepage, S. Roy, A. A. Bizet, and A. Philip
Identification of CD109 as part of the TGF-{beta} receptor system in human keratinocytes
FASEB J, July 1, 2006; 20(9): 1525 - 1527.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-T. Thai and R. T. Ogata
Expression and Characterization of the C345C/NTR Domains of Complement Components C3 and C5
J. Immunol., December 15, 2003; 171(12): 6565 - 6573.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. C. Schuh, N. A. Watkins, Q. Nguyen, N. J. Harmer, M. Lin, J. Y. A. Prosper, K. Campbell, D. R. Sutherland, P. Metcalfe, W. Horsfall, et al.
A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens
Blood, March 1, 2002; 99(5): 1692 - 1698.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020